Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

Showing 1 to 4 of 4

TitleReference numberPublishedLast updated
Risankizumab for treating moderately to severely active ulcerative colitisTA998
Risankizumab for previously treated moderately to severely active Crohn's diseaseTA888
Risankizumab for treating active psoriatic arthritis after inadequate response to DMARDsTA803
Risankizumab for treating moderate to severe plaque psoriasisTA596

Results per page

  1. 10
  2. 25
  3. 50
  4. All